miR-193a-3p prevents tumour progression by targeting TCL1 in diffuse large B-cell lymphoma

miR-193a-3p prevents tumour progression by targeting TCL1 in diffuse large B-cell lymphoma

Abstract Both miR-193a-3p and T-Cell Leukemia/Lymphoma 1 (TCL1) are enriched in the PI3K/AKT signaling pathway, which is pivotal for the regulation of the initiation and progression of diffuse large B-cell lymphoma (DLBCL). Although miR-193a-3p has been demonstrated to exert an inhibitory effect in...

Full description

Saved in:
Bibliographic Details
Main Authors: Haixia Gao, Mengbo Wang, Shuchen Xiong, Ran Zhang, Cancan Wang, Huan Zhang, Wenli Ji, Cuicui Wang, Zhiying Jia, Xinxia Li
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Translational Medicine
Subjects:
miR-193a-3p
TCL1
PI3K/AKT signalling pathway
Diffuse large B-cell lymphoma
Online Access:https://doi.org/10.1186/s12967-025-06689-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items